Treatment of rheumatic disorders. 1912
Naewbigging, T.D.; Young, G.P.; Ritchie, J.; Naewbigging, T.D.; Young, G.P.; Ritchie, J.
Practitioner 256(1750): 28
2012
ISSN/ISBN: 0032-6518 PMID: 22792688 Document Number: 657284
Document emailed within 1 workday
Related Documents
Dick, W.C.; Buchanan, W.W. 1971: Advances in the treatment of rheumatic disorders Practitioner 207(240): 483-491Capone, M.; Castagnoli, M.; Zorzin, L. 1980: Calcitonin in the treatment of osteoporosis in rheumatic disorders La Clinica Terapeutica 95(5): 503-522
Benvenuti, C.; Guidoni, G.; Longoni, A.; Mordini, M. 1983: Controlled study on flurbiprofen and diclofenac in the treatment of rheumatic disorders International Journal of Tissue Reactions 5(1): 61-65
Rhein, E.; Wenig, A. 1970: Clinical experiences in the treatment of rheumatic and non-rheumatic infectious diseases with an antiphlogistic agents Zeitschrift für Allgemeinmedizin 46(29): 1464-1466
Niehues, T.; Horneff, G.; Michels, H.; Sailer Höck, M.; Schuchmann, L. 2004: Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria Zeitschrift für Rheumatologie 63(2): 147-158
Takatsu, T.; Kino, M.; Tsujimoto, G.; Kaku, K.; Sonotani, N.; Suwa, M.; Morita, H.; Hirota, Y.; Tsutsumi, J.; Kubo, S.; Kawamura, K. 1979: Recurrence of rheumatic fever and valvular diseases--etiology of rheumatic fever, rheumatic carditis and recurrent rheumatic fever Nihon Rinsho. Japanese Journal of Clinical Medicine 37(8): 3082-3102
McCauliffe, D.P.; Sontheimer, R.D. 1993: Dermatologic manifestations of rheumatic disorders Primary Care 20(4): 925-941
Boasson, M.; Alix, E.; Teisseire, N.; Renier, J.C. 1980: Cimetidine and rheumatic disorders: preliminary study Revue du Rhumatisme et des Maladies Osteo-Articulaires 47(10): 580-581
Gelfand, S.G. 2000: Functional somatic syndromes in rheumatic disorders Medgenmed: Medscape General Medicine 2(4): E48
Kulkarni, A.V.; Engineer, J.J.; Sequira, R.D.; Borges, N.E.; Joshi, V.R. 1986: Glycoproteins as markers of inflammation in rheumatic disorders Journal of Postgraduate Medicine 32(2): 89-93
Roe, R.L. 1975: The anti-inflammatory agents used in rheumatic disorders Primary Care 2(2): 259-273
Stăvaru, C.; Dolganiuc, A.; Baltaru, D.; Olinescu, A. 1999: The levels of neutrophils oxidative burst in rheumatic disorders Roumanian Archives of Microbiology and Immunology 58(3-4): 241-248
Schaeverbeke, T.; Bébéar, C.M.; Clerc, M.; Lequen, L.; Bébéar, C.; Dehais, J. 1999: What is the role of mycoplasmas in human inflammatory rheumatic disorders? Revue du Rhumatisme 66(1 Suppl): 23s-27s
Dougados, M. 2004: Is there any interest in providing recommendations for the management of rheumatic disorders? Clinical and Experimental Rheumatology 22(2): 141-142
Stoia, I.; Stoia, H. 1974: Osteoporosis caused by digestive disorders with rheumatic symptoms Zeitschrift für Rheumatologie 33(5): 193-197
Lakhanpal, S.; Michet, C.J. 1989: Lymphoreticular disorders masquerading as rheumatic disease syndromes Texas Medicine 85(5): 46-49
Markosian, A.A.; Boterashvili, S.A. 1980: Disorders of external respiration in rheumatic heart defects Klinicheskaia Meditsina 58(11): 69-72
Apostoloff, E. 1982: Use of antirheumatic agents and analgesics in old age in chronic rheumatic disorders Zeitschrift für Arztliche Fortbildung 76(8): 328-330
Moradinejad, M.H.; Ziaee, V. 2011: The incidence of macrophage activation syndrome in children with rheumatic disorders Minerva Pediatrica 63(6): 459-466
Berlin, I.I. 1976: Clinical aspects and therapy of rheumatic disorders of the nervous system Fel'dsher i Akusherka 41(5): 31-36